Abstract:Enhancer of zeste homolog 2 (Ezh2) as a histone methyltransferasehas been reported to epigenetically control gene expression, and it is known to be involved in phenotypic transition and osteogenesis, playing a critical role in multiple inflammatory diseases. Lysosomal transient receptor potential mucolipin 1 (TRPML1) channels regulating lysosome interaction with multivesicular bodies (MVBs) and consequent exosome release play a crucial role in the SMC phenotype transition to osteogenic during arterial medial calcification (AMC). However, there is lack of evidence to show whether Ezh2 participates in the phenotypic transition and vascular calcification process. The aim of this study was to determine the role of Ezh2 in high phosphate (Pi)-induced calcification and to explore its contribution to the phenotype change and exosome secretion in vascular smooth muscle cells (SMCs) that is essential for AMC. Using aortic SMCs isolated from SMC-specific Ezh2 knockout (Ezh2fl/fl/SMCre) mice and wild-type littermates, we demonstrated that high Pi treatment increased more calcium deposition in aortic SMCs as shown by the presence of Alizarin Red-stained nodules when Ezh2 gene is deleted or its activity is inhibited by GSK126. Further, this calcium deposition was significantly decreased by MLSA-1, a TRPML-1 channel agonist in these cells. Correspondingly, Ezh2 gene deletion induced phenotypic change in Pi-treated SMCs, as depicted by decreased SM22-α (SMC marker) and increased expression of osteogenic gene osteopontin in Western blot analysis, indicating that Ezh2 contributes to phenotype change in SMCs leading to calcification nidus formation. Using nanoparticle tracking analysis, Pi-induced secretion of exosomes (100-150 nm in size) were found significantly increased in SMCs, which was augmented by Ezh2 gene deletion or GSK126, or attenuated by MLSA-1. Similarly, GSK126 significantly increased calcification and exosome secretion in Pi-treated and human aortic SMCs (HASMCs), while MLSA-1 markedly decreased calcium deposition and exosome release in these cells. These results suggest that a normal expression of Ezh2 genecritically controls phenotype transition and exosome secretion in arterial SMCs and its defect or deficiency may be an important molecular mechanism leading to AMC.

NEAT1 Regulates VSMC Differentiation and Calcification in As Long Noncoding RNA NEAT1 Enhances Phenotypic and Osteogenic Switching of Vascular Smooth Muscle Cells in Atherosclerosis Via Scaffolding EZH2.

Long Noncoding RNA NEAT1 (nuclear Paraspeckle Assembly Transcript 1) is Critical for Phenotypic Switching of Vascular Smooth Muscle Cells.

Methyltransferase Like 3-Mediated N6-methylatidin Methylation Inhibits Vascular Smooth Muscle Cells Phenotype Switching Via Promoting Phosphatidylinositol 3-Kinase Mrna Decay.

NEAT1 Knockdown Suppresses Endothelial Cell Proliferation and Induces Apoptosis by Regulating Mir‑638/akt/mtor Signaling in Atherosclerosis.

Long noncoding RNA NEAT1 promotes cardiac fibrosis in heart failure through increased recruitment of EZH2 to the Smad7 promoter region

Contribution of Enhancer of Zeste Homolog 2 Gene in Calcification Nidus Formation and Exosome Release in Arterial Smooth Muscle Cells

Enhancer of zeste homolog 2 facilitates phenotypic transition of vascular smooth muscle cells leading to aortic aneurysm/dissection

NEAT1 promotes the repair of abdominal aortic aneurysms of endothelial progenitor cells via regulating miR-204-5p/Ang-1

Autophagy-Sirtuin1(SIRT1) Alleviated the Coronary Atherosclerosis (AS)in Mice through Regulating the Proliferation and Migration of Endothelial Progenitor Cells (EPCs) via wnt/β-catenin/GSK3β Signaling Pathway

Exercise Mitigates Endothelial Pyroptosis and Atherosclerosis by Downregulating NEAT1 Through N6-Methyladenosine Modifications

Smooth Muscle Overexpression of PGC1α Attenuates Atherosclerosis in Rabbits

LncRNA NEAT1 controls the lineage fates of BMSCs during skeletal aging by impairing mitochondrial function and pluripotency maintenance

Long Noncoding RNA NEXN-AS1 Mitigates Atherosclerosis by Regulating the Actin-Binding Protein NEXN

Abstract 1055: Atxn2 Inhibition Enhances The Contractile Phenotype Of Vascular Smooth Muscle Cells

m6A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway

CCAAT/Enhancer-Binding Protein Alpha Is a Novel Regulator of Vascular Smooth Muscle Cell Osteochondrogenic Transition and Vascular Calcification

N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1

Vaspin alleviates the lncRNA LEF1-AS1-induced osteogenic differentiation of vascular smooth muscle cells via the Hippo/YAP signaling pathway

FSCN1 is a Potential Therapeutic Target for Atherosclerosis Revealed by Single-Cell and Bulk RNA Sequencing

NEAT1 Regulates Neuroglial Cell Mediating Aβ Clearance Via the Epigenetic Regulation of Endocytosis-Related Genes Expression

N‐acetylneuraminic acid modulates SQSTM1/p62 sialyation‐mediated ubiquitination degradation contributing to vascular endothelium dysfunction in experimental atherosclerosis mice